I disagree that final FDA approval is "the only news going forward that might affect the share price in any significant way".
ROW's for Retts could be huge and there could be an announcement any day now on that...... Yes - FDA/Lab approval is the ultimate regarding the science and it should happen one day - but that just takes time.
The testing for Angelman being conducted now in Australia is also very promising.... and that might bring good news prior to PMS in USA and also the FDA approval for Pitt Hopkins is probably a given and factored into the current price.
Payments for Retts will flow after final FDA approval later this year, which I think is also a given... but the reality of the $$$$$ should spike the share price again.
It appears that very few people are selling and I am accumulating more right now, when I can afford it.
GLTAH
NEU Price at posting:
$4.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)